BSM vs MTX: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

BSM is the larger of the two ($2.90B market cap): the incumbent the market prices for continued execution (11.90x forward earnings, beta 0.09). MTX is the smaller challenger ($1.91B), cheaper on forward earnings (9.34x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.

BSM vs MTX: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricBSMMTXWhat it tells you
Market cap$2.90B$1.91BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E11.909.34Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Beta0.091.14Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range27% of range18% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book3.571.21How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: MTX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how BSM and MTX affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BSM and MTX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BSM and MTX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Black Stone Minerals (BSM) do?

Black Stone Minerals owns mineral and royalty interests rather than operating wells itself. When oil and gas operators drill and produce on Black Stone's acreage, the partnership collects a royalty (a share of revenue off the top) without paying for the rigs, completion work, or ongoing operating expenses. That structure means very little capital spending of its own, low overhead relative to revenue, and cash flow that converts largely into distributions to unitholders. Its asset base is long-lived and gas-weighted: reserves are roughly 70 percent natural gas and around 88 percent proved developed producing, and it holds mineral interests across roughly 16.9 million gross acres plus additional royalty interests, spanning dozens of states.

Full BSM guide

What does Minerals Technologies (MTX) do?

Minerals Technologies Inc. (NYSE: MTX) is a global specialty minerals company built originally out of Pfizer's minerals unit. It is one of the largest producers of precipitated calcium carbonate (PCC) and the world's largest bentonite producer, and it organizes its business into two segments: Consumer & Specialties (household and personal care products such as cat litter, personal care, fabric care, edible-oil purification, plus specialty additives) at roughly 53% of sales, and Engineered Solutions (high-temperature refractory technologies and environmental and infrastructure products) at roughly 47%. The company sells into paper, packaging, construction, automotive, foundry, steel, and consumer markets across more than 35 countries.

Full MTX guide

BSM vs MTX: how do they differ?

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

  • BSM drivers: Capital-light royalty model; Development agreements and drilling on its acreage.
  • MTX drivers: Diversified specialty-minerals franchise; Return to growth and margin recovery.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Royalty income rises and falls with oil and especially natural gas prices, so revenue and distributions can swing sharply when commodity prices drop; quarterly revenue ranged from about $59 million to about $149 million in the first half of 2026 as derivative marks moved. For MTX, the dominant risk is the talc litigation itself: the reorganization plan must be confirmed and funded, and a large charge (around $290 million booked in 2026) already pressures reported results, turning the second quarter into a GAAP net loss of ~$184 million, with the possibility of adverse rulings or higher-than-expected claim funding.

BSM or MTX: which should you pick?

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BSM if you believe its drivers more; MTX if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BSM and MTX guides.

BSM vs MTX: the full fundamentals

BSM. For a royalty partnership, the numbers to watch differ from a normal stock. Distributable cash flow (DCF) and the distribution coverage ratio matter more than earnings per share, because the payout is the main reason most investors hold the units: coverage above 1.0x means DCF exceeded the distribution, which suggests the payout has cushion, while coverage near or below 1.0x raises the risk of a cut. At $14.85 the units trade near the top of their $12.36 to $15.49 52-week range, at about 12x trailing earnings, with third-quarter results expected around November 2, 2026. The yield looks high partly because the structure passes most cash through, and partly because the income swings with commodity prices. Because BSM is a partnership, you receive a Schedule K-1 (typically by mid-March) rather than a 1099, distributions are largely treated as return of capital that lowers your cost basis, and depletion deductions can shelter part of the income; holding units in an IRA can trigger UBTI complications, so many investors hold them in a taxable account and consult a tax professional.

MTX. With the talc charge pushing trailing GAAP earnings negative, there is no meaningful trailing P/E; on forward estimates (~$6.88 of 2027 EPS) MTX trades at roughly 9 times earnings, about 0.9 times sales and ~7 times EV/EBITDA, a clear discount to the broader chemicals and materials group. That discount reflects the market pricing in talc-litigation uncertainty and a slower top line rather than weak operations, since operating margin is ~13.6% and free cash flow over the trailing year was ~$393 million. The valuation gap is still the crux of the debate, and third quarter results around October 29, 2026 will show whether growth reaccelerates from the second quarter's ~3.7%.

Headline figures (approximate, October 2026): BSM shows revenue (ttm) ~$424 million (+13% yoy in Q2 2026), net income (ttm) ~$254 million (EPS ~$1.20), p/e (trailing / forward) ~12.4x / ~13.2x, distributable cash flow (q2 2026) ~$80 million, coverage 1.18x; MTX shows revenue (ttm) ~$2.15B, q2 2026 revenue ~$548M (up ~3.7% YoY), q2 2026 adjusted eps ~$1.60 (vs ~$1.63 est.), operating margin (ttm) ~13.6%.

The bottom line: BSM vs MTX

BSM and MTX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BSM and MTX exposure against your real portfolio. It is not an investment adviser.

Wondering how BSM or MTX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Black Stone Minerals

Ask Walnut's AI anything about BSM and see how it fits what you own.

FAQ

What is the difference between BSM and MTX?

+

Black Stone Minerals owns mineral and royalty interests rather than operating wells itself. Minerals Technologies Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is BSM or MTX the better stock?

+

Neither is universally better. BSM is the larger incumbent; MTX is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, BSM or MTX?

+

On forward P/E (as of November 2026), BSM trades at 11.90x and MTX at 9.34x, so MTX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both BSM and MTX?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of BSM vs MTX?

+

BSM: Royalty income rises and falls with oil and especially natural gas prices, so revenue and distributions can swing sharply when commodity prices drop; quarterly revenue ranged from about $59 million to about $149 million in the first half of 2026 as derivative marks moved. The distribution is not fixed: the partnership has cut it before (the quarterly rate stepped down from $0.375 to $0.30 during 2025), and a sustained price slump or weak coverage could force another reduction even after the 2026 increase. Mineral interests deplete over time, and Black Stone does not control whether or how fast operators drill on its acreage, so production can stall if activity slows, as the second-quarter Haynesville decline showed; one partner, Revenant, reduced its first-year drilling commitment after a well-control incident. As a limited partnership it issues a Schedule K-1, which adds tax complexity and can create unrelated business taxable income (UBTI) issues if held in a retirement account. Interest rates and energy-sector sentiment also affect how income-oriented units like these are priced. MTX: The dominant risk is the talc litigation itself: the reorganization plan must be confirmed and funded, and a large charge (around $290 million booked in 2026) already pressures reported results, turning the second quarter into a GAAP net loss of ~$184 million, with the possibility of adverse rulings or higher-than-expected claim funding. As a specialty-minerals maker, MTX is exposed to energy, freight, and raw-material cost inflation, which has recently squeezed margins amid geopolitical disruption. Its end markets (paper, construction, steel, and automotive) are cyclical and sensitive to global industrial demand and currency swings given large international exposure. Competition from larger diversified players such as Imerys and Omya can pressure pricing and share. Refinancing the 5.000% 2028 notes with 7.500% notes due 2032 raises interest cost on that slice of debt. Finally, the modest dividend yield and mid-cap size mean the equity can be volatile around litigation and macro headlines.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell BSM or MTX; figures are approximate and dated (as of November 2026). Verify current data before investing.